ARCHIVES

Clinical Trials Approved By NCI Last Month Are Listed

This article is from The Cancer Letter archive.

Vol. 26 No. 8 | August 29, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer PAC Advocated At AACR Meeting

May 23, 1986

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

National Coalition for Cancer Research Formed To Support Reauthorization, l Research Budgets

April 19, 1985

Rewritten Five Year Plan For Centers Is Greeted Warmly By NCAB Committee

April 27, 1990

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002